Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.

Matsuoka K, Hata E, Kaise T, Rudolph C, Hibi T.

Open source

DOI
10.1093/crocol/otag006
Published
2026-01-28
Container
Crohns Colitis 360
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/crocol/otag006,
  title = {Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.},
  author = {Matsuoka K and  Hata E and  Kaise T and  Rudolph C and  Hibi T.},
  year = {2026},
  journal = {Crohns Colitis 360},
  doi = {10.1093/crocol/otag006},
  url = {https://doi.org/10.1093/crocol/otag006}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.
AU  - Matsuoka K
AU  -  Hata E
AU  -  Kaise T
AU  -  Rudolph C
AU  -  Hibi T.
PY  - 2026
JO  - Crohns Colitis 360
DO  - 10.1093/crocol/otag006
UR  - https://doi.org/10.1093/crocol/otag006
ER  - 

APA

K, M., E, H., T, K., C, R., & T., H. (2026). Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.. Crohns Colitis 360. https://doi.org/10.1093/crocol/otag006

Source records